AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs. The R ...

In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of a drug in ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital.

Texas Attorney General Ken Paxton sued Epic this week, alleging that the company is monopolizing the EHR market and restricting patients’ access to their own medical data. Epic’s EHR systems are ...

About 70% of hospital IT pilots fail or face major challenges, according to research from the Standish Group. But it is very rare for hospitals to discuss these setbacks or share studies of ...

The U.S. healthcare system is good at outreach, but engagement is another story. A startup looking to change that raked in millions of dollars on Thursday. Currently, the healthcare system tries to ...

Many healthcare AI startups are changing the way they charge for their technology, moving away from flat subscription rates and toward pricing linked to the financial impact of their tools. Investors ...

PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...

Trust is a major theme flowing through many of the conversations healthcare leaders are having about how to safely and effectively incorporate AI into the field, pointed out Joel Gordon, chief medical ...

Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ...

Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety and ...